Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE)

PROSE (prosthetic replacement of the ocular surface ecosystem) is a pioneering treatment model developed by Boston Foundation for Sight (BFS) to restore vision, support healing, reduce symptoms and improve quality of life for patients suffering with complex corneal disease. PROSE uses FDA-approved custom designed and fabricated prosthetic devices to replace or support impaired ocular surface system functions that protect and enable vision.

• A new transparent, smooth optical surface over the irregular, damaged or diseased cornea.
• An expanded artificial tear reservoir that provides constant lubrication while maintaining necessary oxygen supply.
   

Ocular surface disease (OSD) can be caused by a multitude of etiologies and, when severe, can lead to debilitating symptoms. Treatments for the various causes can be as varied as the disease process itself. Specialized contact lenses have proven to be a potential and cost-effective treatment for a wide variety of conditions, including OSD and corneal ectasia.

• Referral from primary eye care provider, medical doctor or cornea specialist.
• Initial medical review
• Determination of insurance coverage and potential eligibility for free care (1-6 weeks on average)
• Medical consultation to assess candidacy; local and regional consults may be conducted to the financial evaluation process (2-hour visit).
• PROSE treatment (5-10 day-long visits).
• Periodic follow-up visits as required during first 6 months.
• Annual medical evaluation for PROSE treatment.

Patients continue to be followed by their primary eye care provider throughout treatment, and ongoing care is coordinated with primary providers and the PROSE treatment team.

Call US Today for a Consultation

Call us today to learn more or set up a consultation.
Samantha Berezowsky, Patient Coordinator
(713) 798-6109